{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.134","meta":{"versionId":"51","lastUpdated":"2022-02-12T01:02:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.134","version":"20220212","name":"Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment","status":"active","date":"2022-02-12T01:02:18-05:00","publisher":"TJC EH Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"code":"1364445","display":"apixaban 5 MG Oral Tablet"},{"code":"1599543","display":"edoxaban 15 MG Oral Tablet"},{"code":"1599551","display":"edoxaban 30 MG Oral Tablet"},{"code":"1599555","display":"edoxaban 60 MG Oral Tablet"},{"code":"1992427","display":"{74 (apixaban 5 MG Oral Tablet) } Pack"}]}]},"expansion":{"identifier":"urn:uuid:d15942bf-873c-4a68-80a6-234f238ecd32","timestamp":"2022-06-10T10:32:17-04:00","total":6,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1364445","display":"apixaban 5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1599543","display":"edoxaban 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1599551","display":"edoxaban 30 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1599555","display":"edoxaban 60 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1992427","display":"{74 (apixaban 5 MG Oral Tablet) } Pack"}]}}